Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas.

Saved in:
Bibliographic Details
Title: Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas.
Authors: Shah M; Brain Tumour Centre, Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom., Akther Y; Brain Tumour Centre, Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom., Adams CL; Brain Tumour Centre, Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom., Banton MC; School of Biomedical Sciences, University of Plymouth, United Kingdom., Sharma V; School of Biomedical Sciences, University of Plymouth, United Kingdom., Ercolano E; Brain Tumour Centre, Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom., Hilton DA; Cellular and Anatomical Pathology, University Hospitals Plymouth NHS Trust, Derriford Road, Plymouth, PL6 8DH, United Kingdom., Kurian KM; Institute of Clinical Neuroscience, University of Bristol and Southmead Hospital, North Bristol Trust, Bristol, BS8 1QU, United Kingdom., Laraba L; Brain Tumour Centre, Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom., Woznica W; Brain Tumour Centre, Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom., Parkinson DB; Brain Tumour Centre, Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom., de Assis LJ; Brain Tumour Centre, Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom., Hanemann CO; Brain Tumour Centre, Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom. Electronic address: oliver.hanemann@plymouth.ac.uk.
Source: EBioMedicine [EBioMedicine] 2025 Jul; Vol. 117, pp. 105814. Date of Electronic Publication: 2025 Jun 24.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2352-3964
DOI:10.1016/j.ebiom.2025.105814